A60T (p.Ala60Thr) variant of UBQLN2 (Ubiquilin-2)
A60T (p.Ala60Thr) in UBQLN2 (Ubiquilin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
A60T (p.Ala60Thr) variant details
- p.Ala60Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.23
- MetaSVM -0.79
- SIFT 0.07
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available